Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Brain, Behavior, and Immunity
|
August 19, 2008
Don't stress out your immune system - just relax
Thomas J Connor
Immunology
|
April 2, 2004
Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system
Thomas J Connor
British Journal of Pharmacology
|
August 20, 2010
Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?
Noreen T Boyle, Thomas J Connor
European Journal of Pharmacology
|
November 26, 2002
Fenfluramine-induced immunosuppression: an in vivo analysis
Thomas J Connor, John P Kelly
European Journal of Pharmacology
|
August 11, 2007
MDMA ("Ecstasy") suppresses the innate IFN-gamma response in vivo: a critical role for the anti-inflammatory cytokine IL-10
Noreen T Boyle, Thomas J Connor
The International Journal of Neuropsychopharmacology
|
January 18, 2016
Stress-Related Immune Markers in Depression: Implications for Treatment
Martina M Hughes, Thomas J Connor, Andrew Harkin
Neuromodulation : Journal of the International Neuromodulation Society
|
November 10, 2012
Cerebrospinal fluid levels of vascular endothelial growth factor correlate with reported pain and are reduced by spinal cord stimulation in patients with failed back surgery syndrome
Kevin F McCarthy, Thomas J Connor, Connail McCrory
The Journal of Pharmacology and Experimental Therapeutics
|
August 28, 2004
Methylenedioxymethamphetamine suppresses production of the proinflammatory cytokine tumor necrosis factor-alpha independent of a beta-adrenoceptor-mediated increase in interleukin-10
Thomas J Connor, Andrew Harkin, John P Kelly
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 4, 2006
Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade
Michael Diamond, John P Kelly, Thomas J Connor
Pharmacology & Therapeutics
|
March 17, 2006
Immunomodulatory effects of caffeine: friend or foe?
Louise A Horrigan, John P Kelly, Thomas J Connor
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Brain, Behavior, and Immunity
|
August 19, 2008
Don't stress out your immune system - just relax
Thomas J Connor
Immunology
|
April 2, 2004
Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system
Thomas J Connor
British Journal of Pharmacology
|
August 20, 2010
Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?
Noreen T Boyle, Thomas J Connor
European Journal of Pharmacology
|
November 26, 2002
Fenfluramine-induced immunosuppression: an in vivo analysis
Thomas J Connor, John P Kelly
European Journal of Pharmacology
|
August 11, 2007
MDMA ("Ecstasy") suppresses the innate IFN-gamma response in vivo: a critical role for the anti-inflammatory cytokine IL-10
Noreen T Boyle, Thomas J Connor
The International Journal of Neuropsychopharmacology
|
January 18, 2016
Stress-Related Immune Markers in Depression: Implications for Treatment
Martina M Hughes, Thomas J Connor, Andrew Harkin
Neuromodulation : Journal of the International Neuromodulation Society
|
November 10, 2012
Cerebrospinal fluid levels of vascular endothelial growth factor correlate with reported pain and are reduced by spinal cord stimulation in patients with failed back surgery syndrome
Kevin F McCarthy, Thomas J Connor, Connail McCrory
The Journal of Pharmacology and Experimental Therapeutics
|
August 28, 2004
Methylenedioxymethamphetamine suppresses production of the proinflammatory cytokine tumor necrosis factor-alpha independent of a beta-adrenoceptor-mediated increase in interleukin-10
Thomas J Connor, Andrew Harkin, John P Kelly
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 4, 2006
Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade
Michael Diamond, John P Kelly, Thomas J Connor
Pharmacology & Therapeutics
|
March 17, 2006
Immunomodulatory effects of caffeine: friend or foe?
Louise A Horrigan, John P Kelly, Thomas J Connor
Page
of 6